LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 444 participants.

Also called NCT06657326

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 444 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06657326
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Malaysia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06657326. Randomized; single masking; primary purpose treatment. Start 2024-12-18 (actual); primary completion 2026-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients
Condition
Chronic Stable Angina
Condition
Unstable Angina
Condition
Silent Ischemia
Condition
Acute Coronary Syndrome
Intervention (Device)
BioFreedom™ Ultra cobalt-chromium Biolimus A9™-coated stent
Intervention (Device)
BioFreedom™ stainless steel Biolimus A9™-coated stent
Lead sponsor
Biosensors Europe SA (class: industry)

Record details

Record id
cardio:ct-nct06657326
Content hash
e460b3c6cfa06f525332ece32486e6b8d9e8af714a28a4d0ba0f3a7b331cad72